Questions discussed in this category

Is there a preferred strategy of transfusional support versus reduced-dose anticoagulation during the duration of thrombocytopenia?

Would you offer this routinely or only if specific complications arise, such as distal emboli?

Would it make a difference if the VTE diagnosis occurs during bevacizumab therapy or whether it preceded the cancer diagnosis?

Papers discussed in this category

Acta Paediatr., 2020 Mar 23

Blood Transfus, 2018 Oct 24

J Thromb Haemost, 2018 May 08